Altimmune, Inc. - Common Stock (ALT)

Historical Holders from Q3 2018 to Q1 2025

Symbol
ALT on Nasdaq
CUSIP
02155H200
Type / Class
Equity / Common Stock
Shares outstanding
71M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
40.5M
Holdings value
$292M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
183
Number of buys
91
Number of sells
-64
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Altimmune, Inc. - Common Stock (ALT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.7% $32M 6.16M BlackRock, Inc. Dec 31, 2024
AMERIPRISE FINANCIAL INC 7.4% $27.3M 5.25M Ameriprise Financial, Inc. Dec 31, 2024

Institutional Holders of Altimmune, Inc. - Common Stock (ALT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.03M $5.15M +$498K $5.00 23
2024 Q4 40.5M $292M +$7.41M $7.21 183
2024 Q3 39.5M $243M -$19.8M $6.14 168
2024 Q2 42.4M $282M -$21.5M $6.65 175
2024 Q1 44.3M $451M +$96.4M $10.18 167
2023 Q4 33.3M $375M +$81.9M $11.25 140
2023 Q3 30.1M $78.3M -$14.2M $2.60 110
2023 Q2 35.3M $125M -$30M $3.53 118
2023 Q1 40.1M $169M -$115M $4.22 129
2022 Q4 46.8M $770M +$25.9M $16.45 122
2022 Q3 46M $588M +$85.3M $12.77 116
2022 Q2 39.9M $467M +$78.7M $11.70 103
2022 Q1 33.6M $207M +$7.11M $6.09 93
2021 Q4 31.3M $285M -$18.3M $9.16 96
2021 Q3 32.1M $363M +$58.6M $11.31 114
2021 Q2 27.2M $268M +$16.7M $9.85 102
2021 Q1 23.8M $337M +$48.3M $14.13 93
2020 Q4 19.2M $217M -$28.7M $11.28 82
2020 Q3 21.9M $289M +$115M $13.20 67
2020 Q2 13.3M $143M +$125M $10.71 53
2020 Q1 1.58M $5.06M +$1.22M $3.21 18
2019 Q4 1.28M $2.42M +$315K $1.89 21
2019 Q3 1.11M $2.17M +$160K $1.95 22
2019 Q2 1.03M $2.46M -$456K $2.37 15
2019 Q1 1.11M $3.23M +$1.23M $2.90 13
2018 Q4 807K $1.66M +$930K $2.06 16
2018 Q3 194K $852K +$852K $4.40 6